Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank86
Studio
Year-over-Year Change

Price-to-sales ratio

Latest
13.63
↑ 172% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
5.01
Historical baseline
PeriodValueYoY Change
202513.63-62.6%
202436.44-
20230.00-
20220.00-
20210.00-
20200.00-
20190.00-
20180.00-
20170.00-
20160.00-